Hematologic Diseases

Showing NaN - NaN of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Standard Care and Evaluation of NHLBI Patients and Donors

Enrolling by invitation
  • Wide Spectrum of Diseases
  • Hematologic Diseases
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Eosinophilia, Hypereosinophilic Syndrome, Leukocyte Disorder Trial run by the NIAID (prednisone)

    Completed
    • Eosinophilia
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 26, 2022

    Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

    Active, not recruiting
    • Respiratory System Agents
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 20, 2022

    Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

    Recruiting
    • Myelodysplastic Syndrome (MDS)
    • +3 more
    • Cord Blood Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 22, 2021

    Training for Patients With Blood Disorders

    Completed
    • Hematologic Diseases
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 5, 2020

      Natural History Study for BEN

      Completed
      • Neutropenia
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jun 29, 2020

        Hematologic Diseases Trial run by the NHLBI (Interleukin-2 (100,00 IU/m(2) SQ))

        Completed
        • Hematologic Diseases
        • Interleukin-2 (100,00 IU/m(2) SQ)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Mar 13, 2020

        Breast Tumors, Fever, Hematologic Diseases Trial run by the NCI (FLAC chemo with GM-CSF)

        Completed
        • Breast Neoplasms
        • +4 more
        • FLAC chemotherapy with GM-CSF
        • Bethesda, Maryland
          National Cancer Institute (NCI)
        Mar 3, 2008

        Hematologic Diseases, MDS Trial run by the CC (Antithymocyte globulin, Cyclosporine)

        Completed
        • Hematologic Diseases
        • Myelodysplastic Syndromes
        • Bethesda, Maryland
          Warren G. Magnuson Clinical Center (CC)
        Mar 3, 2008